within Pharmacolibrary.Drugs.ATC.D;

model D01AC22
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.01,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 0.01,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Lanoconazole is an imidazole antifungal agent, primarily used topically for the treatment of dermatophyte infections such as tinea corporis and tinea pedis. It has activity against a broad spectrum of fungi but is not widely approved or in clinical use in many countries.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic (PK) parameters have been reported for lanoconazole in human subjects. Lanoconazole is administered topically and is intended for local action with minimal systemic absorption.</p><h4>References</h4><ol><li><p>Imai, H, et al., &amp; Uemura, N (2022). Pharmacokinetics of lanoconazole in human skin after repeated topical application. <i>The Journal of dermatology</i> 49(11) 1118–1123. DOI:<a href=&quot;https://doi.org/10.1111/1346-8138.16515&quot;>10.1111/1346-8138.16515</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35811383/&quot;>https://pubmed.ncbi.nlm.nih.gov/35811383</a></p></li><li><p>Khanna, D, &amp; Bharti, S (2014). Luliconazole for the treatment of fungal infections: an evidence-based review. <i>Core evidence</i> 9 113–124. DOI:<a href=&quot;https://doi.org/10.2147/CE.S49629&quot;>10.2147/CE.S49629</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25285056/&quot;>https://pubmed.ncbi.nlm.nih.gov/25285056</a></p></li><li><p>Niwano, Y, et al., &amp; Yamaguchi, H (1997). Studies on the antifungal activity of the new imidazole antimycotic lanoconazole in infected sites. Distribution in the skin and in vitro activity in the presence of stratum corneum. <i>Arzneimittel-Forschung</i> 47(9) 1056–1060. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9342423/&quot;>https://pubmed.ncbi.nlm.nih.gov/9342423</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D01AC22;
